213 related articles for article (PubMed ID: 21978077)
1. Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.
Goldsbury DE; Smith DP; Armstrong BK; O'Connell DL
BMC Health Serv Res; 2011 Oct; 11():253. PubMed ID: 21978077
[TBL] [Abstract][Full Text] [Related]
2. Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study.
Goldsbury DE; Armstrong K; Simonella L; Armstrong BK; O'Connell DL
BMC Health Serv Res; 2012 Nov; 12():387. PubMed ID: 23140341
[TBL] [Abstract][Full Text] [Related]
3. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
[TBL] [Abstract][Full Text] [Related]
4. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
[TBL] [Abstract][Full Text] [Related]
5. Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.
Luo Q; Yu XQ; Smith DP; Goldsbury DE; Cooke-Yarborough C; Patel MI; O'Connell DL
BMJ Open; 2017 Jan; 7(1):e014259. PubMed ID: 28077413
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care for men with prostate cancer: the 45 and Up Study.
Yap ML; O'Connell DL; Goldsbury DE; Weber MF; Smith DP; Barton MB
Med J Aust; 2021 Apr; 214(6):271-278. PubMed ID: 33665811
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia.
Rodger JC; Supramaniam R; Gibberd AJ; Smith DP; Armstrong BK; Dillon A; O'Connell DL
BJU Int; 2015 Apr; 115 Suppl 5(Suppl Suppl 5):16-23. PubMed ID: 25124107
[TBL] [Abstract][Full Text] [Related]
8. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
Hayen A; Smith DP; Patel MI; O'Connell DL
Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
[TBL] [Abstract][Full Text] [Related]
9. Validation of administrative hospital data for identifying incident pancreatic and periampullary cancer cases: a population-based study using linked cancer registry and administrative hospital data in New South Wales, Australia.
Creighton N; Walton R; Roder D; Aranda S; Currow D
BMJ Open; 2016 Jul; 6(7):e011161. PubMed ID: 27371553
[TBL] [Abstract][Full Text] [Related]
10. Ascertaining invasive breast cancer cases; the validity of administrative and self-reported data sources in Australia.
Kemp A; Preen DB; Saunders C; Holman CD; Bulsara M; Rogers K; Roughead EE
BMC Med Res Methodol; 2013 Feb; 13():17. PubMed ID: 23399047
[TBL] [Abstract][Full Text] [Related]
11. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy.
Goharderakhshan RZ; Grossfeld GD; Kassis A; Shinohara K; Roach M; Carroll PR
Urology; 2000 Oct; 56(4):622-6. PubMed ID: 11018618
[TBL] [Abstract][Full Text] [Related]
12. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
13. Using data linkage to enhance the reporting of cancer outcomes of Aboriginal and Torres Strait Islander people in NSW, Australia.
Tervonen HE; Purdie S; Creighton N
BMC Med Res Methodol; 2019 Dec; 19(1):245. PubMed ID: 31888495
[TBL] [Abstract][Full Text] [Related]
14. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
[TBL] [Abstract][Full Text] [Related]
15. A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer.
Roberts MJ; Papa N; Perera M; Scott S; Teloken PE; Joshi A; Vela I; Pryor D; Martin J; Woo H
BJU Int; 2019 Nov; 124 Suppl 1():31-36. PubMed ID: 31486575
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
[TBL] [Abstract][Full Text] [Related]
17. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
[TBL] [Abstract][Full Text] [Related]
18. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.
Muralidhar V; Mahal BA; Butler S; Lamba N; Yang DD; Leeman J; D'Amico AV; Nguyen PL; Trinh QD; Orio PF; King MT
J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590
[TBL] [Abstract][Full Text] [Related]
19. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
[TBL] [Abstract][Full Text] [Related]
20. International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.
Berlin A; Moraes FY; Sanmamed N; Glicksman R; Koven A; Espin-Garcia O; Leite ETT; Silva JLF; Gadia R; Nesbitt M; Catton CN; Kaffenberger S; Salami SS; Morgan TM; Hearn JWD; Jackson WC; Mehra R; Chung P; Fleshner NE; Zumsteg ZS; Dess RT; Feng FY; Finelli A; Spratt DE
J Urol; 2019 Feb; 201(2):284-291. PubMed ID: 30153435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
